UY32698A - Marcadores de riesgo para enfermedades cardiovasculares - Google Patents

Marcadores de riesgo para enfermedades cardiovasculares

Info

Publication number
UY32698A
UY32698A UY0001032698A UY32698A UY32698A UY 32698 A UY32698 A UY 32698A UY 0001032698 A UY0001032698 A UY 0001032698A UY 32698 A UY32698 A UY 32698A UY 32698 A UY32698 A UY 32698A
Authority
UY
Uruguay
Prior art keywords
cardiovascular diseases
risk markers
risk
markers
kits
Prior art date
Application number
UY0001032698A
Other languages
English (en)
Inventor
Salas Perez-Rasilla Eduardo
Jaime Marrugat De La Iglesia
Roberto Elosua Llanos
Sergio Castillo Fernandez
Joan Salgado Gomez
Jose Maria Ordovas Munoz
Original Assignee
Gendiag Exe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gendiag Exe Sl filed Critical Gendiag Exe Sl
Publication of UY32698A publication Critical patent/UY32698A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Método para determinar el riesgo de padecer una enfermedad cardiovascular en base a la presencia de diferentes polimorfismos, kits para poner en practica dicho método, método para determinar el riesgo en base a uno o más marcadores polimorficos en una muestra de un paciente y medios implementados por computadora para llevar a cabo dicho método.
UY0001032698A 2009-06-09 2010-06-09 Marcadores de riesgo para enfermedades cardiovasculares UY32698A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09162329.8A EP2264183B1 (en) 2009-06-09 2009-06-09 Risk markers for cardiovascular disease

Publications (1)

Publication Number Publication Date
UY32698A true UY32698A (es) 2010-11-30

Family

ID=41061079

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032698A UY32698A (es) 2009-06-09 2010-06-09 Marcadores de riesgo para enfermedades cardiovasculares

Country Status (14)

Country Link
US (1) US9957565B2 (es)
EP (2) EP2264183B1 (es)
AR (1) AR077026A1 (es)
AU (1) AU2010257482B2 (es)
BR (1) BRPI1013082A2 (es)
CA (1) CA2764693C (es)
CL (1) CL2011003129A1 (es)
ES (2) ES2623633T3 (es)
MX (1) MX2011013243A (es)
PE (1) PE20121029A1 (es)
PT (2) PT2264183T (es)
RU (1) RU2524659C2 (es)
UY (1) UY32698A (es)
WO (1) WO2010142713A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
SG10201508656VA (en) 2010-07-09 2015-11-27 Somalogic Inc Lung cancer biomarkers and uses thereof
MX341517B (es) 2010-08-13 2016-08-24 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
DK2554679T3 (en) * 2011-08-05 2016-04-04 Gendiag Exe Sl Genetic markers for risk assessment for cardiovascular disease
MX2014003153A (es) * 2011-09-30 2014-04-30 Somalogic Inc Prediccion de riesgo de evento cardiovascular y usos del mismo.
EP2843056B8 (en) * 2013-08-30 2019-06-26 GENINCODE UK, Ltd. Risk markers for cardiovascular disease in patients with chronic kidney disease
RU2547575C1 (ru) * 2014-02-06 2015-04-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ прогнозирования течения хронической сердечной недостаточности
RU2602451C1 (ru) * 2015-08-28 2016-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации Способ диагностики генетической предрасположенности к развитию ишемического инсульта у больных с фибрилляцией предсердий
WO2017062599A1 (en) * 2015-10-07 2017-04-13 The Board Of Trustees Of The Leland Stanford Junior University Techniques for determining whether an individual is included in ensemble genomic data
RU2624859C1 (ru) * 2016-06-15 2017-07-07 Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Техника") Способ оценки повышенного риска возникновения флеботромбозов у пациентов с ишемической болезнью сердца
CN106250524A (zh) * 2016-08-04 2016-12-21 浪潮软件集团有限公司 一种基于语义信息的机构名抽取方法和装置
US10451544B2 (en) 2016-10-11 2019-10-22 Genotox Laboratories Methods of characterizing a urine sample
WO2019191010A1 (en) * 2018-03-27 2019-10-03 Aardvark Therapeutics Inc. Personalized treatment method for congestive heart failure
US11308325B2 (en) * 2018-10-16 2022-04-19 Duke University Systems and methods for predicting real-time behavioral risks using everyday images
CN110229882A (zh) * 2019-07-03 2019-09-13 贵州省临床检验中心 一种与心血管疾病相关的mthfr基因分子标记及其应用
CN110229881A (zh) * 2019-07-03 2019-09-13 贵州省临床检验中心 一种与成人心血管疾病相关的snp分子标记及其应用
CN112210598A (zh) * 2019-07-11 2021-01-12 合肥中科普瑞昇生物医药科技有限公司 检测高血糖药物代谢相关基因多态性的引物组和试剂盒及它们的应用
CN110607360A (zh) * 2019-09-19 2019-12-24 华中科技大学同济医学院附属同济医院 一种评估慢性心力衰竭预后的引物组、试剂盒及评估慢性心力衰竭预后的方法
EP4132653A4 (en) * 2020-04-11 2024-05-22 Geneticure Inc GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE- AND POST-CORONAVIRUS INFECTIONS
US11574738B2 (en) 2020-04-30 2023-02-07 Optum Services (Ireland) Limited Cross-variant polygenic predictive data analysis
US11482302B2 (en) 2020-04-30 2022-10-25 Optum Services (Ireland) Limited Cross-variant polygenic predictive data analysis
US11978532B2 (en) 2020-04-30 2024-05-07 Optum Services (Ireland) Limited Cross-variant polygenic predictive data analysis
US11610645B2 (en) * 2020-04-30 2023-03-21 Optum Services (Ireland) Limited Cross-variant polygenic predictive data analysis
US11967430B2 (en) 2020-04-30 2024-04-23 Optum Services (Ireland) Limited Cross-variant polygenic predictive data analysis

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US723961A (en) 1902-10-01 1903-03-31 Nelson W Clark Lady's belt, collar, or the like.
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5856522A (en) 1995-05-04 1999-01-05 Tropix, Inc. Method of using synthesis of 1,2-dioxetanes and kits therefore
US5994073A (en) 1990-08-30 1999-11-30 Tropix, Inc. Enhancement of chemiluminescent assays
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
EP0730663B1 (en) 1993-10-26 2003-09-24 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5773628A (en) 1994-11-14 1998-06-30 Tropix, Inc. 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use
US5591591A (en) 1995-02-09 1997-01-07 Tropix, Inc. Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
US5589136A (en) 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions
US5679803A (en) 1995-10-25 1997-10-21 Tropix, Inc. 1,2 chemiluminescent dioxetanes of improved performance
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
US5800999A (en) 1996-12-16 1998-09-01 Tropix, Inc. Dioxetane-precursor-labeled probes and detection assays employing the same
KR100351531B1 (ko) 1997-04-25 2002-09-11 캘리퍼 테크놀로지스 코포레이션 기하형상이 개선된 채널을 채용하는 미소 유체 장치
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
WO2002072889A2 (en) 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US20070015170A1 (en) * 2005-07-12 2007-01-18 Oy Jurilab Ltd Method and kit for detecting a risk of coronary heart disease
RU2322193C1 (ru) 2006-12-04 2008-04-20 Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации Способ оценки генетического риска сердечно-сосудистых заболеваний у спортсменов
CA2679581C (en) * 2007-02-21 2020-12-22 Anna Helgadottir Genetic susceptibility variants associated with arterial disease
US7883851B2 (en) 2007-05-02 2011-02-08 Board Of Regents, The University Of Texas System Common allele on chromosome 9 associated with coronary heart disease

Also Published As

Publication number Publication date
AU2010257482A1 (en) 2012-02-02
EP2264183B1 (en) 2016-12-07
CA2764693A1 (en) 2010-12-16
US20120141450A1 (en) 2012-06-07
BRPI1013082A2 (pt) 2016-07-26
EP2264183A1 (en) 2010-12-22
PE20121029A1 (es) 2012-08-09
PT2440674T (pt) 2017-05-23
PT2264183T (pt) 2017-03-14
CA2764693C (en) 2017-07-11
EP2440674B1 (en) 2017-04-05
MX2011013243A (es) 2012-04-10
CL2011003129A1 (es) 2012-04-27
ES2627446T3 (es) 2017-07-28
RU2524659C2 (ru) 2014-07-27
ES2623633T3 (es) 2017-07-11
AR077026A1 (es) 2011-07-27
AU2010257482B2 (en) 2014-01-23
US9957565B2 (en) 2018-05-01
WO2010142713A1 (en) 2010-12-16
EP2440674A1 (en) 2012-04-18

Similar Documents

Publication Publication Date Title
UY32698A (es) Marcadores de riesgo para enfermedades cardiovasculares
CL2011000298A1 (es) Método para determinar un riesgo aumentado para el desarrollo de la enfermedad de alzheimer en un sujeto, que comprende detectar una variante del gen tomm40;y kit para llevar a cabo el método.
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
BR112014031365A2 (pt) métodos de detectar doenças ou condições
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
BRPI0920779A2 (pt) método de produção de óleo biológico.
BRPI0814670A2 (pt) Método para realizar diagnóstico pré-natal de uma aneuploidia cromossômica fetal.
DOP2013000296A (es) Enfermedad tromboembólica
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
DK2249707T3 (da) Indretning til automatiseret screening for medfødte hjertesygdomme
BR112012013418A2 (pt) marcador sérico bioquímico.
PE20160603A1 (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica
CY1116083T1 (el) Μεθοδος για τον εντοπισμο τυπων του ιου των ανθρωπινων θηλωματων (hpv)
BRPI0920426A2 (pt) metodo para prever um ritmo biologico de um individuo.
BRPI0914098A2 (pt) biosensor
ITBO20080103A1 (it) Microarray per l'analisi di sequenze nucleotidiche
WO2010015538A3 (en) Predictive marker for egfr inhibitor treatment
IT1394172B1 (it) Metodo prognostico
BRPI0924560A2 (pt) Métodos e kits para detectar, diagnosticar e monitorar doenças
DK2031401T3 (da) Automatiseret proteinanalysefremgangsmåde
FI20095189A0 (fi) Henkilönostimen tikkaat, henkilönostin sekä menetelmä henkilönostimen tikkaiden käyttämiseksi
WO2008125738A8 (en) A method for selecting responders to blockade of integrin receptors